2023年6月30日

得克薩斯州奧斯汀市,2023年6月29日——基於保險精神衛生保健提供者,專業治療抑鬱症和創傷患者帶來了450萬美元的一係列擴展。主要投資Gron企業和果醬基金,額外的支持一個加速器,泰爾資本,神秘的企業,Gaingels, Antifund。這筆資金將授權去進入新市場和投資規模的保健和分析平台。“種族隔離和一維精神衛生係統已經失敗患者中,許多人等待太久經驗保健提供真正和持久的解脫。我們自豪的支持誌同道合的投資者認為,這需要改變,“共享的創始人和CEO,西蒙Tankel。”標題的綜合,病人首次方法是增壓的結果——更快。個性化、combination-service保健計劃一個屋簷下,可以通過保險計劃,迅速提高了病人的生活質量和他們的親人。”Heading is a tech-enabled mental health care provider that urgently drives towards optimal outcomes for patients experiencing severe depression and trauma, particularly those that have been failed by past encounters within the medical system. Prioritizing interventions with the highest probability of clinical outcomes, such as Spravato®, ketamine, and TMS as well as MDMA and psilocybin if approved, Heading clinicians monitor and integrate the latest research with real-time patient measurements to lower total cost of care, delivering value to health plans partners and broad access to those seeking the highest quality affordable care. Heading drives patient outcomes through proprietary pathways incorporating psychotherapy, psychiatry, and nutrition together with interventional modalities, with plans for psychedelic therapeutics in the approval pipeline. With recent technology hire Maxim Osipov holding a PhD in Computational Psychiatry, Heading's team are industry-veterans in clear-minded approaches to effective mental healthcare that prioritizes impact for those who need it most. Founded in Austin in 2020, Heading has locations in Austin and the Dallas-Fort Worth metros, with plans to expand further in 2023 in Dallas and Houston. Heading is an in-network provider with nearly every commercial payer in the state of Texas including BCBS of Texas, United Healthcare, Cigna, Aetna, and Tricare. About Heading Heading is an Austin-based mental health company founded in 2020 by Co-founder Steve Levine, MD and CEO, Simon Tankel. By combining evidence-based practices, personalized treatment plans, and a commitment to patient-centric care, Heading is transforming the mental health landscape and providing lasting relief to those in need. Today Heading offers a continuum of in-network mental health services for hard to treat conditions including interventional psychiatric services like intramuscular ketamine, Spravato®, and TMS in their centers, along with psychiatry and therapy conveniently available through telehealth. Heading has locations in the Austin and Dallas-Forth Worth metros, with plans for further expansion in Dallas and a first location in Houston later this year. Contact: Julia Lopez